AYI Stock Analysis: Acuity Brands | NYSE
Electrical Equipment & Parts | NYSE, USA | Market Cap: 10.895m USD | 12M Return: 26.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 135M
EPS Trend: 95.9%
Qual. Beats: 0
Rev. Trend: 87.7%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
Average return per month, with how dependable it is below — did the month move the same way every year (high) or randomly (low). Above 60 is a pattern worth trusting; under 40 is noise.
Acuity Inc. (NYSE: AYI), headquartered in Atlanta, Georgia and incorporated in 2001, operates as a provider of lighting, lighting controls, building management systems, and audio/video/control platforms across the United States and international markets. The company runs two segments: Acuity Brands Lighting (ABL), which supplies luminaires and lighting solutions under numerous proprietary brands (including Lithonia Lighting, Juno, Gotham, Holophane, and nLight) to electrical distributors, consumer retailers, large corporate accounts, and OEMs; and Acuity Intelligent Spaces (AIS), which offers Distech Controls building management systems, the Q-SYS AV/control platform, and QSC audio technology to venues such as retail stores, airports, universities, sports facilities, and hospitality properties. The company was formerly known as Acuity Brands, Inc. and adopted its current name in March 2025.
Acuity sits within the Industrials sector under the Electrical Components & Equipment sub-industry, and its business model reflects a broader shift in the lighting industry from commodity fixtures toward integrated smart-building solutions, where lighting hardware is increasingly bundled with controls, sensors, and software platforms that target energy efficiency and connected building management.
- Commercial construction slowdown weighs on ABL segment sales
- AIS segment margins expand as QSC and Distech scale
- Share repurchases continue as core capital allocation priority
| Net Income: 472.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 2.89 > 1.0 |
| NWC/Revenue: 18.02% < 20% (prev 18.94%; Δ -0.92% < -1%) |
| CFO/TA 0.16 > 3% & CFO 722.7m > Net Income 472.3m |
| Net Debt (499.4m) to EBITDA (831.5m): 0.60 < 3 |
| Current Ratio: 2.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (31.0m) vs 12m ago -1.94% < -2% |
| Gross Margin: 49.31% > 18% (prev 47.40%; Δ 1.91% > 0.5%) |
| Asset Turnover: 99.26% > 50% (prev 89.72%; Δ 9.54% > 0%) |
| Interest Coverage Ratio: 19.80 > 6 (EBIT TTM 667.3m / Interest Expense TTM 33.7m) |
| A: 0.18 (Total Current Assets 1.62b - Total Current Liabilities 788.3m) / Total Assets 4.64b |
| B: 1.00 (Retained Earnings 4.63b / Total Assets 4.64b) |
| C: 0.14 (EBIT TTM 667.3m / Avg Total Assets 4.64b) |
| D: 1.60 (Book Value of Equity 2.85b / Total Liabilities 1.78b) |
| Altman-Z'' = 7.07 = AAA |
| DSRI: 0.91 (Receivables 610.9m/608.6m, Revenue 4.61b/4.17b) |
| GMI: 0.96 (GM 47.40% / 49.31%) |
| AQI: 0.97 (AQ_t 0.56 / AQ_t-1 0.57) |
| SGI: 1.10 (Revenue 4.61b / 4.17b) |
| TATA: -0.05 (NI 472.3m - CFO 722.7m) / TA 4.64b) |
| Beneish M = -3.08 (Cap -4..+1) = AA |
As of July 01, 2026, the stock is trading at USD 376.66 with a total of 344,930 shares traded. Over the past week, the price has changed by +26.10%, over one month by +22.69%, over three months by +34.51% and over the past year by +26.56%.
Current recommended Stop Loss: 357.00 (which is 5.2% or 1.3 ATR below the current price).
Acuity Brands has received a consensus analysts rating of 4.11. Therefore, it is recommended to buy AYI.
- StrongBuy: 4
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 352.5 | -6.4% |
P/E Trailing = 23.8639
P/E Forward = 16.9779
P/S = 2.3751
P/B = 3.8208
P/EG = 1.4947
Revenue TTM = 4.61b USD
EBIT TTM = 667.3m USD
EBITDA TTM = 831.5m USD
Long Term Debt = 697.3m USD (from longTermDebt, last quarter)
Short Term Debt = 27.0m USD (from shortTermDebt, last quarter)
Debt = 911.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 107.0m
Net Debt = 499.4m USD (calculated: Debt 911.3m - CCE 411.9m)
Enterprise Value = 11.4b USD (10.9b + Debt 911.3m - CCE 411.9m)
Interest Coverage Ratio = 19.80 (Ebit TTM 667.3m / Interest Expense TTM 33.7m)
EV/FCF = 17.82x (Enterprise Value 11.4b / FCF TTM 639.4m)
FCF Yield = 5.61% (FCF TTM 639.4m / Enterprise Value 11.4b)
FCF Margin = 13.88% (FCF TTM 639.4m / Revenue TTM 4.61b)
Net Margin = 10.25% (Net Income TTM 472.3m / Revenue TTM 4.61b)
Gross Margin = 49.31% ((Revenue TTM 4.61b - Cost of Revenue TTM 2.33b) / Revenue TTM)
Gross Margin QoQ = 50.62% (prev 49.29%)
Tobins Q-Ratio = 2.46 (Enterprise Value 11.4b / Total Assets 4.64b)
Interest Expense / Debt = 3.70% (Interest Expense 33.7m / Debt 911.3m)
Taxrate = 21.07% (126.1m / 598.4m)
NOPAT = 526.7m (EBIT 667.3m * (1 - 21.07%))
Current Ratio = 2.05 (Total Current Assets 1.62b / Total Current Liabilities 788.3m)
Debt / Equity = 0.32 (Debt 911.3m / totalStockholderEquity, last quarter 2.85b)
Debt / EBITDA = 0.60 (Net Debt 499.4m / EBITDA 831.5m)
Debt / FCF = 0.78 (Net Debt 499.4m / FCF TTM 639.4m)
Total Stockholder Equity = 2.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.18% (Net Income 472.3m / Total Assets 4.64b)
RoE = 16.85% (Net Income TTM 472.3m / Total Stockholder Equity 2.80b)
RoCE = 19.07% (EBIT 667.3m / Capital Employed (Equity 2.80b + L.T.Debt 697.3m))
RoIC = 14.45% (NOPAT 526.7m / Invested Capital 3.64b)
WACC = 11.06% (E(10.9b)/V(11.8b) * Re(11.74%) + D(911.3m)/V(11.8b) * Rd(3.70%) * (1-Tc(0.21)))
Discount Rate = 11.74% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -15.56 | Cagr: -0.63%
[DCF] Terminal Value 69.73% ; FCFF base≈586.2m ; Y1≈672.0m ; Y5≈989.0m
[DCF] Fair Price = 315.2 (EV 10.1b - Net Debt 499.4m = Equity 9.55b / Shares 30.3m; r=11.06% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 95.86 | EPS CAGR: 12.34% | SUE: 0.56 | # QB: 0
Revenue Correlation: 87.66 | Revenue CAGR: 7.60% | SUE: 1.04 | # QB: 1
EPS next Quarter (2026-11-30): EPS=5.07 | Chg30d=-0.04% | Revisions=-11% | Analysts=5
EPS current Year (2026-08-31): EPS=19.52 | Chg30d=+0.02% | Revisions=-67% | GrowthEPS=+8.4% | GrowthRev=+5.1%
EPS next Year (2027-08-31): EPS=21.25 | Chg30d=-0.11% | Revisions=-54% | GrowthEPS=+8.9% | GrowthRev=+6.3%
[Analyst] Revisions Ratio: -67%